Seoul, South Korea

Hayun Lee

This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Cj Cheiljedang Corporation, Lg Electronics Inc.. Active years: 2017-2026.

USPTO Granted Patents = 8 

% Patents Active = 87.5

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hayun Lee: Innovator in Biochemical Engineering

Introduction

Hayun Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biochemical engineering, particularly in the area of amino acid production. With a total of 8 patents to his name, Lee has established himself as a key figure in innovation.

Latest Patents

Among his latest patents is the invention of an isopropylmalate synthase polypeptide variant. This innovative variant is crucial for a method of producing L-leucine, an essential amino acid. The patent titled "Isopropylmalate Synthase Variant and a Method of Producing L-Leucine Using the Same" showcases his expertise in biochemical processes.

Career Highlights

Hayun Lee has worked with notable companies such as LG Electronics Inc. and CJ CheilJedang Corporation. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the industry.

Collaborations

Lee has collaborated with talented individuals in his field, including Cheolsoo Kim and Bumgi Min. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

In summary, Hayun Lee is a distinguished inventor whose work in biochemical engineering has led to significant advancements in amino acid production. His innovative patents and collaborations highlight his commitment to pushing the boundaries of science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…